Projects funded by the NCN
Designing Active Inhibitors of SARS-CoV-2 Methyltransferases
2023/49/N/NZ7/03794
Keywords:
Coronaviruses SARS-CoV-2 methyltransferase activity RNA capping small molecular inhibitors drug-design platform in-silico screening antiviral therapeutics
Descriptors:
- NZ7_16:
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Jagielloński, Małopolskie Centrum Biotechnologii Uniwersytetu Jagiellońskiego
woj. małopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 2
Call: PRELUDIUM 22 - announced on 2023-03-16
Amount awarded: 140 000 PLN
Project start date (Y-m-d): 2024-01-16
Project end date (Y-m-d): 2026-01-15
Project duration:: 24 months (the same as in the proposal)
Project status: Project completed
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
Publications will be made available after the final report has been accepted.